Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Establishment of a canine urothelial carcinoma-derived organoid biobank: A platform for comparative and translational research.
PMID 41889014 · PMC13140855 · Clinical and translational medicine · 2026 · 8 claims · 6 setups
Canine urothelial carcinoma closely resembles human muscle-invasive bladder cancer in histopathology, molecular features, biological behavior, metastatic patterns, therapeutic response, and clinical outcome
-
Full-text index only
Keratin 5 marks cancer-propagating cells sustained by an osteopontin-producing niche in high-grade serous ovarian carcinoma.
PMID 42111394 · PMC13155427 · Cancer heterogeneity and plasticity · 2026 · 8 claims · 8 setups
KRT5+ cells represent bona fide cancer-propagating cells (CPCs) in HGSC
-
Full-text index only
MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer.
PMID 41529070 · PMC13136877 · Cancer research · 2026 · 7 claims · 8 setups
EVI1, encoded by MECOM, is an AR-recruited coactivator of noncanonical AR signaling in prostate cancer.
-
Full-text index only
A Plastic EMP1+ to LGR5+ Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal Cancer.
PMID 41128661 · PMC12877754 · Cancer discovery · 2026 · 8 claims · 8 setups
RMC-9945 exerts durable antitumor activity in early-stage liver metastasis but has diminished therapeutic effect in advanced metastatic disease
-
Full-text index only
Interferon-γ selectively promotes survival of alveolar progenitor cells in a human lung organoid model.
PMID 41992061 · PMC13187038 · The EMBO journal · 2026 · 8 claims · 7 setups
A new human ALVO model supports long-term expansion of alveolar progenitor cells and defined serum-free differentiation into AT1-like cells, improving on prior HTII-280-selection/serum-based protocols
-
Full-text index only
A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules.
PMID 41534092 · PMC13044530 · Cancer research · 2026 · 8 claims · 8 setups
SWI/SNF-targeting PROTAC treatment reduces viability of CRPC-WNT (AR-negative) cell lines and organoids, not just AR-dependent CRPC
-
Full-text index only
Pulmonary organoid models demonstrate compositionally driven epithelial plasticity and immune polarization.
PMID 41940331 · PMC13049529 · iScience · 2026 · 8 claims · 7 setups
Cellular composition at seeding (PD vs. BAL vs. Mixed) directs epithelial fate and immune polarization in organoid culture
-
Full-text index only
Protocol for generating and characterizing Matrigel-free prostate cancer patient-derived organoids.
PMID 41955100 · PMC13091043 · STAR protocols · 2026 · 7 claims · 7 setups
A Matrigel-free culture protocol improves both take-rate and proportion of tumor cells within PCa PDO cultures compared to traditional Matrigel-based approaches
-
Full-text index only
Ex Vivo Immuno-Oncology Platform Reveals Spatial T-cell Infiltration Patterns Linked to ATR Inhibition Responses in High-Grade Serous Ovarian Cancer.
PMID 41563843 · PMC7618831 · Cancer immunology research · 2026 · 8 claims · 8 setups
iPDCs cultured on human omentum gel (OmGel) recapitulate tumor genomic and histologic characteristics while retaining intratumoral immune cells
-
Has reproduction · 85
Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma.
PMID 33634984 · PMC7882098 · Clinical and translational medicine · 2021 · 8 claims · 8 setups
JMJD6 is identified as a potent epigenetic vulnerability/fitness gene in RCC by integrating GeCK CRISPR screening data with TCGA-KIRC epigenetic regulator survival analysis
-
Full-text index only
ROR1-PI3K/AKT signaling drives adaptive resistance to cell cycle blockade in TP53 mutated ovarian cancer.
PMID 41748546 · PMC13004963 · Cell death & disease · 2026 · 7 claims · 8 setups
A shared PI3K/AKT-regulated signaling node governs drug adaptation across all long-term resistant (lt-res) ADA and PTX models
-
Full-text index only
NDUFA4L2 regulates the progression and chemotherapy sensitivity of HNSCC by inhibiting PANoptosis.
PMID 41787028 · PMC13087130 · NPJ precision oncology · 2026 · 8 claims · 8 setups
Elevated NDUFA4L2 expression is associated with poor survival and chemotherapy resistance in HNSCC